Clinical Trial

Good-first: B/F/TAF As First-line ART

Recruiting

Record status

This record was last updated October 1, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

This is a multicohort study conducted at Affiliated Hospital of Nantong University, and Nantong Third Peoples Hospital (Designated Hospital for HIV/AIDS Treatment of Nantong City), China. The study would involve 630 patients initiating HIV treatment, divided into six cohorts. The enrollment period for the prospective cohort is from July 2024 to June 2025, while the enrollment period for the retrospective cohort is from January 2020 to June 2023.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-09-26.

Trial Details

NCT Number	NCT06619288
Lead Sponsor	Affiliated Hospital of Nantong University Collaborators: Nantong Third Peoples Hospital
Conditions	HIV Infection
Enrollment	630 participants
Start Date	2024-07-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2024-10-01